Innovative Concepts in Drug Development Overview

  • Founded
  • 2007
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 5
Employees
  • Latest Deal Type
  • M&A

Innovative Concepts in Drug Development General Information

Description

Provider of proprietary screening platforms designed to achieve targeted research to accelerate drug development and bring greater benefits to the patient. The company's platform helps to reduce product development costs by developing and making available the appropriate decision-making tools and product development technologies, enabling researchers to tackle some of the more difficult to treat diseases that are associated with high overall costs to society, such as neurodegenerative diseases.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Parent Company
GeneStore
Primary Office
  • 800 Avenue du Château de Jouques
  • 13420 Gémenos
  • France
+33 04 00 00 00 00
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Innovative Concepts in Drug Development Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Merger/Acquisition 01-Jan-2019 00.000 Completed Generating Revenue
4. Grant 01-Jan-2014 00.000 Completed Generating Revenue
3. Later Stage VC 15-Jan-2013 00.000 00.000 Completed Generating Revenue
2. Accelerator/Incubator 29-Nov-2012 $1.64M Completed Generating Revenue
1. Capitalization 01-Jan-2009 $1.64M $1.64M Completed Generating Revenue
To view Innovative Concepts in Drug Development’s complete valuation and funding history, request access »

Innovative Concepts in Drug Development Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Innovative Concepts in Drug Development Former Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
CDPS Angel Group Minority 000 0000 000000 0
Grand Delta Angels Angel Group Minority 000 0000 000000 0
Incubateur Impulse Accelerator/Incubator 000 0000 000000 0
Michael J. Fox Foundation Limited Partner 000 0000 000000 0
Région Sud Investissement Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 6 investors. Get the full list »